D.E. Shaw & Co’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

D.E. Shaw & Co’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-220,646	Closed	-$75K	–	4938
2024 Q1	$75K	Hold	220,646	–	–	﹤0.01%	4023
2023 Q4	$44.6K	Hold	220,646	–	–	﹤0.01%	4028
2023 Q3	$43.9K	Hold	220,646	–	–	﹤0.01%	3928
2023 Q2	$30.9K	Hold	220,646	–	–	﹤0.01%	3926
2023 Q1	$11.7K	Hold	220,646	–	–	﹤0.01%	4213
2022 Q4	$14.2K	Hold	220,646	–	–	﹤0.01%	4570
2022 Q3	$15K	Hold	220,646	–	–	﹤0.01%	4861
2022 Q2	$25K	Hold	220,646	–	–	﹤0.01%	4970
2022 Q1	$88K	Hold	220,646	–	–	﹤0.01%	5023
2021 Q4	$146K	Hold	220,646	–	–	﹤0.01%	4976
2021 Q3	$152K	Buy	220,646 +158,482	+255%	+$127K	﹤0.01%	4631
2021 Q2	$58K	Buy	+62,164	New	+$49.6K	﹤0.01%	4613

Other funds holding AONCW

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

D.E. Shaw & Co's AONCW Position: Q2 2024 in Review

D.E. Shaw & Co sold out of American Oncology Network, Inc. Warrant (AONCW) in Q2 2024, closing a stake of 220,646 shares — an estimated $75K sold.

D.E. Shaw & Co first reported a position in AONCW in Q2 2021 and held it in 12 quarters. The position peaked at $152K in Q3 2021. 3 funds tracked by Wall St. Rank hold AONCW as of Q2 2024.

D.E. Shaw & Co reported no remaining American Oncology Network, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
D.E. Shaw & Co sold 220,646 American Oncology Network, Inc. Warrant shares in Q2 2024, an estimated $75K.
D.E. Shaw & Co first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 12 quarters.
D.E. Shaw & Co's American Oncology Network, Inc. Warrant position peaked at $152K in Q3 2021.
3 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.